PlexusDx charges a flat monthly fee at $189/mo month-to-month, or from $149/mo on the 6-month plan for compounded semaglutide injection, with no insurance required, no membership fees, and HSA/FSA eligibilitymaking precision weight loss therapy financially accessible to more patients
3 The takeaway: Behavior change matters to people on GLP-1s, and the Noom app continues to be associated with stronger real-world GLP-1 outcomes Taken together, these findings tell a clear story: people who pair GLP-1 medication with consistent engagement in the Noom app see more success at weight loss, and, independently, they stay with the program longer
Early research suggests this area is worth studying, but retatrutide-specific human evidence is limited
Tirzepatide is a once-weekly injectable medication approved by the FDA for the treatment of type 2 diabetes mellitus (marketed as Mounjaro) and chronic weight management in adults with obesity or overweight with weight-related comorbidities (marketed as Zepbound)